{
    "nctId": "NCT05020574",
    "briefTitle": "Microbiome and Association With Implant Infections",
    "officialTitle": "Microbiome and Association With Implant Infections: Investigating the Impact of Antibiotics on the Gut and Breast Microbiomes Post-mastectomy With Implant-based Breast Reconstruction",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Breast Cancer Female, Genetic Predisposition to Disease",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "Proportion of tissue samples obtained successfully over time",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Patients must have histologically confirmed breast malignancy OR genetic predisposition to breast cancer.\n2. Age \\>= 18 years\n3. Scheduled to undergo mastectomy with the immediate placement of tissue expanders or implant placement\n4. Ability to understand a written informed consent document, and the willingness to sign it\n5. At least 4 weeks post-completion of chemotherapy or radiation therapy.\n\nExclusion Criteria:\n\n1. Any significant medical condition or laboratory abnormalities, which places the subject at unacceptable risk if he/she were to participate in the study\n2. Pregnant or breastfeeding\n3. Patients who have taken antibiotics within 90 days of the consent date\n4. Patients who have taken probiotics within 90 days of the consent date\n5. Patients who have a documented or reported allergic reaction to the outlined antibiotics to be used in this study\n6. Male patients",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}